Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — hormone support for healthy aging

Breast cancer is not one disease — it encompasses many distinct types with different attributes, degrees of invasiveness and treatment responses. Understanding the difference between invasive and non-invasive cancers, what hormone receptor status means, and which risk factors are modifiable can help women make more informed decisions about screening, lifestyle and hormone health. This article provides a clear, evidence-based overview.

When sex hormone test results show both oestradiol (E2) and progesterone (Pg) within normal ranges, yet symptoms persist, the Pg/E2 ratio provides a critical additional layer of clinical insight. A low ratio points to oestrogen dominance; a high ratio to progesterone dominance — each requiring a different therapeutic response. This article explains how the ratio is calculated, when it is clinically relevant, and how a real-world case illustrates its practical value.

In 1999, Tina Mattern was diagnosed with breast cancer and faced a terrifying choice of conventional treatments. Instead, she discovered the work of Dr. David Zava and ZRT Laboratory, and chose a path of natural hormone balancing, saliva testing and lifestyle change. This is her story — and her happy ending.